During a median 5-year follow-up period, seroconversion occurred in 5.7% and 5.3% of the MPO-ANCA- and PR3-ANCA-positive patients, respectively, with 25% of the MPO-ANCA-positive or seroconverted patients developing MPA [34]. Here, PRTN3 is linked to microscopic polyangiitis.